oral immunomodulators (Enzo)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameoral immunomodulators (Enzo)
Drug Alias Nameimmune regulation therapy (Enzo)hepatocellular carcinoma treatment (Enzo)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsGraft vs Host DiseaseCarcinoma, HepatocellularHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnzo Biochem Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnzo Biochem Inc
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseCarcinoma, HepatocellularHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A